Centre for the AIDS Programme of Research in South Africa

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy

Completed

Conditions: Tuberculosis

First Posted Date: 2012-02-27

Last Posted Date: 2017-02-02

Lead Sponsor: Centre for the AIDS Programme of Research in South Africa

Target Recruit Count: 402

Registration Number: NCT01539005

Locations: 🇿🇦
CAPRISA eThekwini Clinical Research Site, Durban, KwaZulu Natal, South Africa

Trial to Assess the Impact of PrEP to Tenofovir Gel on the Efficacy of Tenofovir-containing ART on Viral Suppression

Not Applicable

Completed

Conditions: Antiretroviral Treatment Outcomes

Interventions: Drug: Tenofovir, lamivudine and efavirenz

First Posted Date: 2011-07-01

Last Posted Date: 2017-04-20

Lead Sponsor: Centre for the AIDS Programme of Research in South Africa

Target Recruit Count: 59

Registration Number: NCT01387022

Locations: 🇿🇦
CAPRISA, Durban, KwaZulu-Natal, South Africa

Reducing HIV in Adolescents

Phase 2

Completed

Conditions: HIV Infections

Interventions: Behavioral: Cash incentives
Behavioral: Life skills curriculum

First Posted Date: 2010-08-25

Last Posted Date: 2017-01-19

Lead Sponsor: Centre for the AIDS Programme of Research in South Africa

Target Recruit Count: 3217

Registration Number: NCT01187979

Locations: 🇿🇦
Vulindlela Clinical Research Site, Durban, KwaZulu-Natal, South Africa

Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV

Phase 2

Completed

Conditions: HIV Infections

Interventions: Drug: Tenofovir gel
Drug: Placebo (Universal HEC placebo)

First Posted Date: 2007-02-28

Last Posted Date: 2016-02-01

Lead Sponsor: Centre for the AIDS Programme of Research in South Africa

Target Recruit Count: 889

Registration Number: NCT00441298

Locations: 🇿🇦
CAPRISA eThekwini Clinical Research Site, Durban, KwaZulu-Natal, South Africa
🇿🇦
CAPRISA, Vulindlela Clinical Research Site, Pietermaritzburg, KwaZulu-Natal, South Africa

An Enhanced Adherence Support Programme for Highly Active Antiretroviral Therapy (HAART)

Phase 3

Completed

Conditions: HIV Infections

Interventions: Behavioral: Standard adherence support
Behavioral: Enhanced adherence support

First Posted Date: 2006-12-07

Last Posted Date: 2016-02-01

Lead Sponsor: Centre for the AIDS Programme of Research in South Africa

Target Recruit Count: 297

Registration Number: NCT00408642

Locations: 🇿🇦
CAPRISA eThekwini Clinical Research Site, Durban, KwaZulu-Natal, South Africa

A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients

Phase 3

Completed

Conditions: HIV Infections
Tuberculosis

Interventions: Drug: Early versus intermediate versus late initiation of ART

First Posted Date: 2006-11-14

Last Posted Date: 2011-03-24

Lead Sponsor: Centre for the AIDS Programme of Research in South Africa

Target Recruit Count: 642

Registration Number: NCT00398996

Locations: 🇿🇦
CAPRISA eThekwini Clinical Research Site, Durban, KwaZulu-Natal, South Africa

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy